Swiss Foreign Minister to Asharq Al-Awsat: Riyadh Agreement Is a Step for The Right Track in Yemen

Swiss Vice President and Foreign Minister Ignazio Cassis (Asharq Al-Awsat)
Swiss Vice President and Foreign Minister Ignazio Cassis (Asharq Al-Awsat)
TT

Swiss Foreign Minister to Asharq Al-Awsat: Riyadh Agreement Is a Step for The Right Track in Yemen

Swiss Vice President and Foreign Minister Ignazio Cassis (Asharq Al-Awsat)
Swiss Vice President and Foreign Minister Ignazio Cassis (Asharq Al-Awsat)

Swiss Vice President and Foreign Minister Ignazio Cassis stressed the importance of Tehran’s return to the negotiations on the nuclear program, hoping that its ongoing talks with Riyadh would have a positive impact on the region’s security and stability.

In an interview with Asharq Al-Awsat, Cassis said that every agreement that supports de-escalation of the conflict and alleviates the suffering of the Yemeni people is a step in the right direction, noting that from this point of view stems the importance of the Riyadh Agreement.

In his statements, he stressed the importance of finding a comprehensive and peaceful solution for the future of Yemen, reiterating Switzerland's call on all parties to abide by international law and stop attacks on civilians. He also said his country calls on all parties to re-engage in negotiations to end the violence and find a political solution.

Underlining his country’s support to the United Nations Special Envoy for Yemen, Hans Grundberg, Cassis said it is important that the international community, and in particular regional actors, work towards reaching a political solution to the crisis.

On the ongoing rounds of negotiations between Saudi Arabia and Iran, the official asserted that only a comprehensive understanding between the countries of the region would lead to peace, stability, and prosperity in the long run.

He noted that the ongoing talks between Saudi Arabia and Iran are a good sign.

Asked about talks on Iran’s nuclear program, Cassis said the JCPOA progress is an essential contribution to international security and non-proliferation.

He added that as a non-signatory, Switzerland does not participate directly in the Vienna process. However, the country welcomes the news about the imminent resumption of talks and hopes that this will lead to a speedy and full return to the commitments of all parties.

Regarding Libya, Cassis said the country has suffered from various conflicts for more than 10 years, stressing that the ceasefire agreement signed in Geneva in October 2020 was the first sign of hope.

He highlighted several achievements that took place, including what he described as the free and inclusive elections, which are expected to be held by the end of 2021.

According to Cassis, Switzerland has been supporting the UN-led peace process for many years and will continue to provide services and stand by Libya on its path to sustainable peace and unity.

On relations with Saudi Arabia, he revealed that his visit to Riyadh would touch on means to strengthen his country’s ties with the Kingdom and deepen development cooperation.

Noting that Switzerland has adopted a strategy for the Middle East and North Africa (MENA) region in October, he said that his visit would be largely devoted to the implementation of this strategy, which builds on Switzerland’s longstanding commitment to conflict prevention, humanitarian assistance, and the promotion of development cooperation.

Cassis said his country also seeks to highlight the opportunities available to Swiss companies in the Saudi market, as well as Switzerland's relentless pursuit to harness the potential of the young, well-educated workforce and work to promote digitalization and new technologies.

Asked about previous bilateral agreements and whether his visit to Riyadh would witness the signing of new cooperation projects, Cassis said he believes that through the free trade agreement between the European Free Trade Association and the Gulf Cooperation Council countries, in addition to the double taxation agreement and the bilateral investment agreement, it is possible to say that relations with Saudi Arabia rest on a solid foundation.

On efforts to combat climate change, the minister stressed that Switzerland welcomed the efforts made by all countries to mitigate and adapt to climate threats.

He noted that climate change is an excellent example of a global challenge that can only be faced together.

Cassis also said that Switzerland and Saudi Arabia share many interests in the 2030 Agenda for Sustainable Development, adding that priority topics included ways to improve water and health, address climate change, and enhance agriculture and food security.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.